MedPath

Effects of WB-EMS in Ulcerative Colitis Patients

Not Applicable
Withdrawn
Conditions
Ulcerative Colitis
Registration Number
NCT02144129
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

The purpose of this study is to determine the effect of 12 weeks of WB-EMS either applicated passive in a supine resting position or active during slight movements compared with a non-training control group on body composition, muscle strength and QoL in patients with ulcerative colitis.

Our main hypothesis is that active WB-EMS application is significantly more favorable to address our primary endpoints compared with passive application.

Our secondary hypothesis is that passive WB-EMS application is significantly more favorable to address our primary endpoints compared with non-training control.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • ulcerative colitis
  • ambulatory subjects
Exclusion Criteria
  • variables that conflicts with WB-EMS application (e.g. cardiac pacemakers)
  • absence of more than two weeks during the interventional period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Lean Body Mass12 weeks, baseline to 12 week follow-up

Lean Body Mass (LBM) and Appendicular Skeletal Muscle Mass (ASMM) as assessed by Dual-Energy-x-Ray Absorptiometry (DXA)

Isokinetic muscle strength12 weeks, baseline to 12 week follow-up

Isokinetic muscle strength of the leg extensors and - flexors as assessed by a isokinetic leg strength

Secondary Outcome Measures
NameTimeMethod
Quality of Life (QoL)12 weeks, baseline to 12 week follow-up

QoL as assessed by inflammatory bowel disease questionnaire (IBDQ-D) and Depression Scores

Isometric muscle strength12 weeks, baseline 12 week follow-up

Isometric strength of the trunk flexors.

Trial Locations

Locations (1)

Medizinische Klinik 1, University of Erlangen-Nurnberg

🇩🇪

Erlangen, Franconia, Germany

Medizinische Klinik 1, University of Erlangen-Nurnberg
🇩🇪Erlangen, Franconia, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.